✦FLY PARROTS✦SPRING 2026✦STRATEGY · GO-TO-MARKET✦FBC PORTFOLIO ✦FLY PARROTS✦SPRING 2026✦STRATEGY · GO-TO-MARKET✦FBC PORTFOLIO

Spring 2026·PROJECT 03 / 13

Fly Parrots

Neurocare AI / ML — Alzheimer's care

StrategyGo-to-marketInvestor outreach

— Overview

Our team developed a targeted go-to-market and investment strategy for Fly Parrots' product, Polly, focused on the Alzheimer's care market. We created a three-phase roadmap: 1) pilot programs with clinical validation, 2) institutional adoption, and 3) partnerships scaling. We then conducted outreach to Alzheimer's clinics to test market entry. In parallel, we built an investor strategy by identifying high-fit Alzheimer's and healthtech investors, mapping them across growth stages, and creating outreach materials (LinkedIn messaging and one-pagers) to initiate fundraising conversations.

— Deliverables

✓Three-phase go-to-market roadmap: clinical validation pilots → institutional adoption → partnership-led scale
✓Outreach to Alzheimer's clinics to test market entry and validate the product with clinical champions
✓Investor strategy: high-fit Alzheimer's and healthtech investors mapped across credibility, adoption, growth, and capital stages
✓Tailored investor outreach package: LinkedIn messaging, one-pagers, and pitch materials to initiate fundraising conversations

— Testimonial

In the client's words.

"

Working with FBC was an outstanding experience. The team helped Parrots Medical sharpen its Alzheimer's go-to-market strategy, identify more relevant clinical and investor pathways, and translate research into clear, actionable recommendations. Their work was thoughtful, professional, and genuinely valuable to our next stage of growth.

David Hojah
Co-Founder & CEO, Parrots Medical · Spring 2026

← Previous project

Nonprofit Management Solutions

Next project →

Valley Business Partners